Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsDESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.
A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?
High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.
Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.
1.
Breast cancer surgery: Study finds overnight hospital stay not important for older patients
2.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
3.
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
4.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection
5.
A healthier lifestyle after bowel screening shown to prevent bowel cancer
1.
Omentum Cancer: Causes, Symptoms, and Treatment Options
2.
Pediatric Multisystem Developmental Interactions: Mechanisms, Clinical Implications, and Evidence-Based Management
3.
Digital Morphology Libraries for Hematology Education: Transforming Diagnostic Training and Clinical Practice
4.
Clinical Pharmacology of Hypoxia-Activated Anticancer Prodrugs
5.
Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Recognizing Symptoms of Vitamin B12 Deficiency
2.
Understanding the Common Causes of Anemia
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
4.
Current Scenario of Cancer- Q&A Session to Close the Gap
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge